These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34668612)

  • 1. Loss of SMARCB1 promotes autophagy and facilitates tumour progression in chordoma by transcriptionally activating ATG5.
    Li M; Shen Y; Xiong Y; Wang S; Li C; Bai J; Zhang Y
    Cell Prolif; 2021 Dec; 54(12):e13136. PubMed ID: 34668612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
    Huang S; Qi P; Zhang T; Li F; He X
    Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-30a-5p suppresses lung squamous cell carcinoma via ATG5 - mediated autophagy.
    Yang J; Rao S; Cao R; Xiao S; Cui X; Ye L
    Aging (Albany NY); 2021 Jul; 13(13):17462-17472. PubMed ID: 34253689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy.
    Wang J; Qi Q; Zhou W; Feng Z; Huang B; Chen A; Zhang D; Li W; Zhang Q; Jiang Z; Bjerkvig R; Prestegarden L; Thorsen F; Wang X; Li X; Wang J
    Autophagy; 2018; 14(11):2007-2022. PubMed ID: 30025493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCB1 Loss in Poorly Differentiated Chordomas Drives Tumor Progression.
    Walhart TA; Vacca B; Hepperla AJ; Hamad SH; Petrongelli J; Wang Y; McKean EL; Moksa M; Cao Q; Yip S; Hirst M; Weissman BE
    Am J Pathol; 2023 Apr; 193(4):456-473. PubMed ID: 36657718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-34a inhibits progression of neuroblastoma by targeting autophagy-related gene 5.
    Cheng X; Xu Q; Zhang Y; Shen M; Zhang S; Mao F; Li B; Yan X; Shi Z; Wang L; Sheng G; Zhang Q
    Eur J Pharmacol; 2019 May; 850():53-63. PubMed ID: 30716314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer.
    Hong SH; Son KH; Ha SY; Wee TI; Choi SK; Won JE; Han HD; Ro Y; Park YM; Eun JW; Nam SW; Han JW; Kang K; You JS
    Cancer Res; 2021 Jan; 81(2):356-370. PubMed ID: 33239431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
    Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
    Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic Correlates of the Abscopal Effect in a SMARCB1/INI1-negative Poorly Differentiated Chordoma after EZH2 Inhibition and Radiotherapy.
    Gounder MM; Zhu G; Roshal L; Lis E; Daigle SR; Blakemore SJ; Michaud NR; Hameed M; Hollmann TJ
    Clin Cancer Res; 2019 Apr; 25(7):2064-2071. PubMed ID: 30642912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia.
    Chatterjee SS; Biswas M; Boila LD; Banerjee D; Sengupta A
    Mol Cancer Res; 2018 May; 16(5):791-804. PubMed ID: 29483235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
    Radko-Juettner S; Yue H; Myers JA; Carter RD; Robertson AN; Mittal P; Zhu Z; Hansen BS; Donovan KA; Hunkeler M; Rosikiewicz W; Wu Z; McReynolds MG; Roy Burman SS; Schmoker AM; Mageed N; Brown SA; Mobley RJ; Partridge JF; Stewart EA; Pruett-Miller SM; Nabet B; Peng J; Gray NS; Fischer ES; Roberts CWM
    Nature; 2024 Apr; 628(8007):442-449. PubMed ID: 38538798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers.
    Sasaki M; Kato D; Murakami K; Yoshida H; Takase S; Otsubo T; Ogiwara H
    Nat Commun; 2024 Jun; 15(1):4770. PubMed ID: 38839769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High sensitivity of FISH analysis in detecting homozygous SMARCB1 deletions in poorly differentiated chordoma: a clinicopathologic and molecular study of nine cases.
    Owosho AA; Zhang L; Rosenblum MK; Antonescu CR
    Genes Chromosomes Cancer; 2018 Feb; 57(2):89-95. PubMed ID: 29119645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of ATG5-dependent macroautophagy by chaperone-mediated autophagy promotes breast cancer cell metastasis.
    Han Q; Deng Y; Chen S; Chen R; Yang M; Zhang Z; Sun X; Wang W; He Y; Wang F; Pan X; Li P; Lai W; Luo H; Huang P; Guan X; Deng Y; Yan J; Xu X; Wen Y; Chen A; Hu C; Li X; Li S
    Sci Rep; 2017 Jul; 7(1):4759. PubMed ID: 28684853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
    Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA-ATB promotes autophagy by activating Yes-associated protein and inducing autophagy-related protein 5 expression in hepatocellular carcinoma.
    Wang CZ; Yan GX; Dong DS; Xin H; Liu ZY
    World J Gastroenterol; 2019 Sep; 25(35):5310-5322. PubMed ID: 31558875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
    Zhang YF; Li CS; Zhou Y; Lu XH
    Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningeal SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily B member 1 (SMARCB1)-deficient tumours: an emerging group of meningeal tumours.
    Dadone B; Fontaine D; Mondot L; Cristofari G; Jouvet A; Godfraind C; Varlet P; Ranchère-Vince D; Coindre JM; Gastaud L; Baudoin C; Peyron AC; Thyss A; Coutts M; Michiels JF; Pedeutour F; Burel-Vandenbos F;
    Neuropathol Appl Neurobiol; 2017 Aug; 43(5):433-449. PubMed ID: 27732747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
    Darr J; Klochendler A; Isaac S; Eden A
    Oncogene; 2014 Jun; 33(23):3024-32. PubMed ID: 23851500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.